Centinel Spine receives FDA 510(k) clearance for its FLX Platform of 3D-printed all-titanium devices: 4 insights

Centinel Spine received FDA 510(k) clearance for its FLX Platform of Integrated Interbody and non-integrated interbody fusion devices.

Advertisement

Here are four things to know:

1. The FLX Platform consists of 3D-printed, all-titanium devices with a combination of solid and porous radiolucent sections intended to reduce mechanical stiffness and improve visibility relative to solid titanium implants.

2. The devices feature the proprietary Fuse-Thru trabecular scaffold, which is engineered to allow for bony in-growth and on-growth throughout the implant.

3. Stalif FLX Integrated Interbody devices are indicated for use at one or two contiguous levels with both autograft and/or allogenic bone graft.

4. Centinel Spine is the largest privately-held spine company and is focused on anterior column reconstruction.

More articles on surface technology:

Camber Spine receives FDA clearance for titanium ALIF device: 3 insights

Oxford Performance Materials teams up with JSR Corp. to advance PEKK line in Asia: 4 insights

K2M receives FDA clearance for patient-specific BACS platform: 5 things to know

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.